72048624R00003: Community and Organizational Resilience and Empowerment to Reduce, manage, and mitigate the risk (of emerging and re-emerging) Infectious Diseases (CORE2RID)
Closed
This grant is closed. Who won this program's grants before is below, and similar open grants are at the end of the page. It is in our archive of Thailand USAID-Bangkok notices from 2024.
Thailand USAID-Bangkok offered grants to the applicants described in the notice. Applications closed on September 20, 2024.
From the official notice on Grants.gov, last changed October 11, 2024. Checked November 7, 2026.
- Award amountsNot given on Grants.gov
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | September 6, 2024 |
|---|---|
| Deadline | September 20, 2024 |
| Archived by Grants.gov | October 20, 2024 |
Who can apply
This opportunity was open to the applicants described in the notice.
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
Local organizations in Thailand
Is this a realistic fit?
- Most of the program's money (54% over five years) went to nonprofits.
- No cost sharing or match is required.
What the grant funds
The United States Agency for International Development, Regional Development Mission for Asia (USAID/RDMA) is in the process of gathering information to support the design of the “Community and Organizational Resilience and Empowerment to Reduce, manage, and mitigate the risk (of emerging and re-emerging) Infectious Diseases (CORE2RID) ” activity. This RFI seeks for feedback from the public on the attached Activity Description.
Who has won USAID Foreign Assistance for Programs Overseas grants before
From fiscal 2021 to 2025, USAID Foreign Assistance for Programs Overseas (98.001) awarded $37 billion across 4,233 grant awards, an average of $8.7 million per award.
| Recipient | State | Awards | Amount |
|---|---|---|---|
| Miscellaneous Foreign Awardees | District of Columbia | 489 | $6.9 billion |
| Family Health International | North Carolina | 91 | $2.1 billion |
| Catholic Relief Services - United States Conference of Catholic Bishops | Maryland | 128 | $1.2 billion |
| Save the Children Federation, Inc. | Connecticut | 100 | $814 million |
| Research Triangle Institute | North Carolina | 33 | $756 million |
Applying now
This notice no longer takes applications. Agencies often post the same opportunity again under a new number, so check the program's notices on Grants.gov and the similar open grants below.
The notice on Grants.gov keeps its full text and attachments, which is useful for planning a resubmission.
Questions people ask
Is 72048624R00003 still open?
No. It closed on September 20, 2024.
Who can apply for Community and Organizational Resilience and Empowerment to Reduce, manage, and mitigate the risk (of emerging and re-emerging) Infectious Diseases (CORE2RID)?
Thailand USAID-Bangkok accepted applications from the applicants described in the notice. The notice adds further conditions, so read its eligibility section.
What is the deadline for Community and Organizational Resilience and Empowerment to Reduce, manage, and mitigate the risk (of emerging and re-emerging) Infectious Diseases (CORE2RID)?
Closed September 20, 2024. Applications are no longer accepted; the program's newer notices are on this page when there are any.
Who has won USAID Foreign Assistance for Programs Overseas grants before?
The largest recipients over five fiscal years were Miscellaneous Foreign Awardees, Family Health International, Catholic Relief Services - United States Conference of Catholic Bishops. The program made 4,233 awards worth $37 billion in that time.
Similar open grants
- Single Source for the Continuation of the Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
- Single Source for the Continuation of the Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Center (Collaborative U01 Clinical Trial Not Allowed)
- Data Coordinating Center for the Aging and Alzheimer’s Disease Mouse Brain Atlas (AD-MBA) (U24 Clinical Trial Not Allowed)
- Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)